Sakthivel M S, Prabha Ratna, Singh Onkar, Kekre Nitin S, Kumar Santosh
Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.
Consultant Urologist, Kalyani Kidney Care Centre, Erode, Tamil Nadu, India.
Indian J Urol. 2018 Oct-Dec;34(4):287-291. doi: 10.4103/iju.IJU_107_18.
Drugs causing ureteral relaxation are used for medical expulsive therapy (MET) for stones. We investigated the ability of tadalafil to cause relaxation of potassium chloride (KCl)-induced contractions of isolated human ureteral tissue.
Eight grossly normal proximal ureteral tissues were collected from the radical and donor nephrectomy specimen. The standard organ bath protocol was followed. Ureteral contractions were induced with 80 mM KCl before and after exposure to tadalafil.
The median amplitude and frequency of KCl-induced contractions and the median area under the contractility curve (AUCC) after exposure to 20 μM tadalafil showed significant reductions compared to that of before exposure to tadalafil (7.87 cm, 3.79/min, and 2.98 cm, respectively, versus 9.37 cm, 4.48/min, and 4.50 cm, respectively; = 0,026, 0.008, and 0.008, respectively). After exposure to 40 μM tadalafil, the median amplitude and frequency of KCl-induced contractions and AUCC (4.50 cm, 2.56/min, and 0.92 cm, respectively) showed significant reductions compared to that of before exposure to tadalafil (7.62 cm, 3.88/min, and 3.32 cm, respectively; = 0.008, 0.016, and 0.008, respectively). However, reductions in the parameters after exposure to 20 μM and 40 μM tadalafil were similar ( = 0.065, 0.195, and 0.130, respectively, for median amplitude, frequency, and AUCC).
Tadalafil reduces KCl-induced contractions of isolated human ureteral tissue . No incremental relaxations in contractions occurred by increasing the dose of tadalafil from 20 μM to 40 μM.
用于结石药物排石治疗(MET)的药物可使输尿管松弛。我们研究了他达拉非使氯化钾(KCl)诱导的离体人输尿管组织收缩松弛的能力。
从根治性肾切除术和供体肾切除术标本中收集8个大体正常的近端输尿管组织。遵循标准的器官浴方案。在暴露于他达拉非之前和之后,用80 mM KCl诱导输尿管收缩。
与暴露于他达拉非之前相比,暴露于20 μM他达拉非后,KCl诱导收缩的中位幅度、频率以及收缩力曲线下的中位面积(AUCC)均显著降低(分别为7.87 cm、3.79次/分钟和2.98 cm,而之前分别为9.37 cm、4.48次/分钟和4.50 cm;P分别为0.026、0.008和0.008)。暴露于40 μM他达拉非后,KCl诱导收缩的中位幅度、频率和AUCC(分别为4.50 cm、2.56次/分钟和0.92 cm)与暴露于他达拉非之前相比显著降低(分别为7.62 cm、3.88次/分钟和3.32 cm;P分别为0.008、0.016和0.008)。然而,暴露于20 μM和40 μM他达拉非后参数的降低相似(中位幅度、频率和AUCC的P分别为0.065、0.195和0.130)。
他达拉非可降低KCl诱导的离体人输尿管组织收缩。将他达拉非的剂量从20 μM增加到40 μM时,收缩的松弛程度没有增加。